Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Summary not available.
Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of health care solutions, will hold an Investor Meeting on February 27, 2023, at 9:00 a.m. Eastern time. This event will showcase the company's BOLD +1 Strategic Plan aimed at achieving sustainable growth. Key executives, including Stanley M. Bergman and Ronald N. South, will present financial guidance for 2023 and a long-term outlook. Registration is available on the Investor Relations website.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, will release its fourth quarter and full-year 2022 financial results on February 16, 2023. The earnings conference call will begin at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the call via www.henryschein.com/IRwebcasts. Henry Schein serves over 1 million customers worldwide, offering solutions for dental and medical practitioners. With sales of $12.4 billion in 2021, it continues to grow within the health care sector.
Summary not available.
Henry Schein (NASDAQ: HSIC) announced its subsidiary, eAssist Dental Solutions, has acquired a majority stake in Unitas PPO Solutions. This strategic acquisition aims to enhance eAssist's revenue cycle services and improve dental practice insurance and billing processes. The acquisition builds on a long-standing partnership and is expected to be neutral to 2022 diluted earnings per share, becoming accretive thereafter. Unitas generated sales of approximately $5 million in 2021 and its integration will help streamline operations and improve cash flow for dental practices.
Henry Schein (NASDAQ: HSIC) announced its successful Cares Hygiene Pack Program, aiding over 27,000 Ukrainians during the humanitarian crisis. Health care clients purchased over 200 hygiene packs, including essentials like toothbrushes and soap, assembled by more than 300 Team Schein Members across various locations, including the U.S. and Europe. Notable partners, MedShare and International Medical Corps, supported distribution in Ukraine and Poland. This initiative reflects Henry Schein’s commitment to emergency preparedness and enhancing the health and dignity of those affected.
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions to dental and medical practitioners, announced its participation in two key investor conferences. The Goldman Sachs Healthcare CEOs Unscripted Conference will take place on January 5, 2023, at 10:35 a.m. Eastern time. Following this, the 41st Annual J.P. Morgan Healthcare Conference is scheduled for January 11, 2023, at 9:00 a.m. Pacific time. Live webcasts of these presentations will be available on the company's investor relations site.
Henry Schein (Nasdaq: HSIC) announced a definitive agreement to acquire a majority stake in Biotech Dental S.A.S., a fast-growing provider of clinical software and oral surgery products based in France. The acquisition aims to expand Henry Schein's offerings in key dental categories, including implants and aligners. The transaction, subject to regulatory approvals, is expected to be slightly dilutive to 2023 earnings per share, primarily due to non-cash acquisition accounting adjustments. Biotech Dental reported approximately $100 million in revenue for 2021.
Henry Schein (NASDAQ: HSIC) recently celebrated the 24th annual Holiday Cheer for Children program, aiding over 1,700 individuals in need across multiple countries including the U.S., Australia, and Canada. Team Schein Members donated toys, clothing, and gift cards valued for 500 local children, supported by the Henry Schein Cares Foundation. The initiative focuses on uplifting families during the holiday season, showcasing the company's commitment to community welfare and social responsibility. Collaborations with 10 social service organizations enhance the program's outreach.
Henry Schein One has launched Dentrix Detect AI, an AI-driven X-ray analysis tool in collaboration with VideaHealth, aimed at enhancing dental practices. This integration allows for real-time clinical decision support and simplifies workflows by automatically analyzing images without the need for manual import/export. Dentists can now offer immediate feedback and treatment recommendations to patients, improving case acceptance rates. The software, currently available to qualified Dentrix users, leverages VideaHealth’s FDA-cleared detection capabilities to ensure precise diagnostics.